Effectiveness of a manual therapy protocol based on articulatory techniques in migraine patients. A randomized controlled trial.
Featured on Physle Daily · Wednesday, 21 October 2026
Migraine is often managed with medication, but there is ongoing debate about whether hands-on physiotherapy techniques that move joints (articulatory techniques) can meaningfully help. This trial compared a four-week manual therapy protocol against a placebo treatment in 50 people with migraine, assessing pain, disability, quality of life, medication use, and patients' own sense of change. People who received the manual therapy reported less pain intensity than the placebo group both immediately after treatment and a month later, along with less migraine-related disability at follow-up, better physical and overall quality of life right after treatment, lower medication use at both time points, and a more positive sense of overall change. No serious adverse events were reported.
The main limitation is the small size of the trial, with only 25 participants per group, which limits how confidently these results can be generalized.
If you live with migraine, you may have wondered whether physiotherapy involving hands-on joint techniques can actually help, beyond medication. This study tested that question in 50 people with migraine, comparing a real manual therapy treatment against a placebo version over four weekly sessions. People who received the real treatment reported feeling less pain afterward and a month later, used less medication, and reported improvements in how migraine affected their daily life and overall quality of life, compared to those who got the placebo treatment.
They also reported feeling more positively changed overall. No serious side effects were reported. It's encouraging that these effects lasted at least a month, but this was a small study with only 25 people in each group.
That means these results are promising rather than conclusive, and larger studies would help confirm whether this kind of manual therapy reliably helps people with migraine.
This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.
This randomized controlled trial addresses whether articulatory manual therapy techniques offer measurable benefit for migraine patients beyond a placebo intervention, a question with ongoing clinical debate. Fifty participants were randomized to a four-week, four-session manual therapy protocol or a placebo condition, with outcomes assessed before treatment, immediately after, and at one-month follow-up using MIDAS (Migraine Disability Assessment), SF-36 quality of life, medication intake, and patient-reported global change. The manual therapy group showed significant between-group improvements in pain intensity at both post-treatment and follow-up (large effect sizes, d around 1.1), migraine disability at follow-up (d = 0.69), physical and overall quality of life post-treatment (d = 0.72 and 0.60), and reduced medication intake at both timepoints.
These findings suggest articulatory techniques may contribute to reductions in pain and medication use, informing clinical reasoning about adjunctive manual therapy roles in migraine management, though as a placebo-controlled design, expectation effects within the intervention itself are less likely to fully explain results. However, with only 25 participants per arm, this remains a small trial, and the abstract does not report longer-term outcomes beyond one month, limiting conclusions about durability or generalizability to broader migraine populations. No adverse events were reported.
In this small randomized controlled trial of 50 migraine patients, a manual therapy protocol using articulatory techniques reduced pain intensity more than placebo both right after treatment and at one-month follow-up.
Compared with placebo, the manual therapy group showed significant improvements in migraine disability at one-month follow-up, physical and overall quality of life after treatment, and reduced medication intake at both time points.
The trial was small (25 per group), so these findings need confirmation in larger studies before confidence in the size and durability of the effects can be considered strong.
Source
Musculoskeletal science & practice
Muñoz-Gómez E, Inglés M, Serra-Añó P et al. · 2021
doi: 10.1016/j.msksp.2021.102386